Stefan Bader is a 3rd-year PhD Candidate at the Olivia Newton-John Cancer Research Institute (ONJCRI) in Heidelberg, VIC, Australia. He studied Technical Biology and Technical Business Administration at The University of Stuttgart (UoS) and is holding a degree (German Diploma, equivalent to a 5-year Bachelor + Master degree) from UoS. During his studies he completed a research internship and seminar paper in the department of New Biological Entities (NBE) at Boehringer Ingelheim in Biberach/Riss (Germany) investigating treatment options for chronic obstructive lung disease (COPD). He finished his Diploma Thesis in early 2015 in the department of Biomedical Engineering at UoS analyzing various antibody-fusion proteins for targeted cancer immunotherapy. After completing his degree at UoS, he conducted a research internship at King Abdullah University of Science and Technology (KAUST) in Saudi Arabia, where he undertook research at the KAUST Catalysis Centre (KCC).
In late 2016 he commenced his PhD project, which is a collaboration between breast cancer experts from ONJCRI and cancer nanomedicine specialists from the Monash Institute of Pharmaceutical Sciences (MIPS) and the ARC Centre of Excellence in Bio-Nano Science (CBNS). The multi-disciplinary project is focused on investigating a nanoparticle-based drug delivery system for the treatment of metastatic breast cancer. During the project, he’s been based both at MIPS and ONJCRI to conduct the chemical work, in vitro experiments (MIPS/CBNS) and in vivo studies (ONJCRI). Strongly committed to cancer research, Stefan’s main interests lay at the interface of basic cancer research, cancer immunotherapy and cancer nanomedicine.
You can find Stefan on: